A New Hope for Pancreatic Cancer: PARP Inhibitors in Tumors With BRCA Mutations

Review this CCO on-demand Webcast with downloadable slides from the 2019 ASCO GI live satellite symposium.

Share

Program Content

Activities

Mutations in Pancreatic Cancer
Overview of Germline and Somatic Mutations in Pancreatic Cancer
Case Challenge
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 17, 2019

Expires: January 16, 2020

PARP inhibitors in PDAC
DNA Damage Repair Defects as a Therapeutic Target in Pancreatic Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 17, 2019

Expires: January 16, 2020

Trials in DDRm PDAC
Ongoing Clinical Trials and Combination Strategies in PDAC With Germline or Somatic DDR Mutations
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 17, 2019

Expires: January 16, 2020

Activities

PARP Inhibitors in Pancreatic Cancer
A New Hope for Pancreatic Cancer: PARP Inhibition in Tumors With BRCA Mutations
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 08, 2019

Expires: March 06, 2020

Faculty

cover img faculity

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

cover img faculity

Tanios Bekaii-Saab, MD

Professor of Medicine
Mayo Clinic College of Medicine and Science
Leader
Gastrointestinal Cancer Program
Mayo Clinic Cancer Center
Phoenix, Arizona

cover img faculity

Eileen O Reilly, MD

Associate Professor
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca